Hki Liquid
NDC Package 62106-0625-0
Package Information
Hki (atropinum sulphuricum, benzoicum acidum, berberis vulgaris, calcarea carbonica, colocynthis, coccus cacti, lapis albus, lithium carbonicum, lycopodium clavatum, oryctolagus cuniculus kidney, rubia tinctorum, sarsaparilla, urtica urens) liquids is usesHelps promote and maintain healthy kidney and urinary tract functions.DirectionsTo be taken 20 minutes away from food.Place drops directly under the tongue or into ¼ oz of water.Adults and adolescents (12 years and older): Take 10 drops two to three times daily or as recommended by your healthcare practitioner.Children (under 12 years): Take under the direction of your healthcare practitioner. This formulation utilizes a liquid delivery system. Marketed by Seroyal Usa, this product is identified by NDC 62106-0625.
Identification & Billing
Clinical Specifications
- ATROPINE SULFATE 6 [hp_X]/30mL
- BENZOIC ACID 6 [hp_X]/30mL
- BERBERIS VULGARIS ROOT BARK 5 [hp_X]/30mL
- CALCIUM HEXAFLUOROSILICATE 12 [hp_C]/30mL
- CITRULLUS COLOCYNTHIS FRUIT PULP 6 [hp_X]/30mL
- LITHIUM CARBONATE 6 [hp_X]/30mL
- LYCOPODIUM CLAVATUM SPORE 5 [hp_X]/30mL
- ORYCTOLAGUS CUNICULUS KIDNEY 10 [hp_X]/30mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 12 [hp_X]/30mL
- PROTORTONIA CACTI 5 [hp_X]/30mL
- RUBIA TINCTORUM ROOT 4 [hp_X]/30mL
- SARSAPARILLA 1 [hp_X]/30mL
- URTICA URENS 1 [hp_X]/30mL
- Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
- Anticholinergic - [EPC] (Established Pharmacologic Class)
- Cholinergic Antagonists - [MoA] (Mechanism of Action)
- Cholinergic Muscarinic Antagonist - [EPC] (Established Pharmacologic Class)
- Cholinergic Muscarinic Antagonists - [MoA] (Mechanism of Action)
- Mood Stabilizer - [EPC] (Established Pharmacologic Class)
- Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 62106 - Seroyal Usa
- 62106-0625 - Hki
- 62106-0625-0 - 1 BOTTLE, GLASS in 1 CARTON / 30 mL in 1 BOTTLE, GLASS
- 62106-0625 - Hki
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62106-0625-0 identifies a specific commercial package of 1 bottle, glass in 1 carton / 30 ml in 1 bottle, glass of Hki, a human over the counter drug labeled by Seroyal Usa. This liquid is formulated for sublingual use and contains atropine sulfate; benzoic acid; berberis vulgaris root bark; calcium hexafluorosilicate; citrullus colocynthis fruit pulp; lithium carbonate; lycopodium clavatum spore; oryctolagus cuniculus kidney; oyster shell calcium carbonate, crude; protortonia cacti; rubia tinctorum root; sarsaparilla; urtica urens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Seroyal Usa on December 14, 2015. The current certification is valid through December 31, 2026.
How is this Seroyal Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62106062500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.